Αρχική World News FDA grants accelerated approval to vusolimogene oderparepvec-wtpg in combination with nivolumab for... World News FDA grants accelerated approval to vusolimogene oderparepvec-wtpg in combination with nivolumab for melanoma Από Ogkologos - 30 Σεπτεμβρίου, 2026 89 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the IGNYTE study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ EMA recommends granting a marketing authorisation for daraxonrasib Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? MOST POPULAR FDA Approves HPV Tests That Allow for Self-Collection in a Health... 24 Ιουλίου, 2024 EMA Recommends Granting a Conditional Marketing Authorisation for Obecabtagene Autoleucel 26 Αυγούστου, 2025 FDA Approves Lutetium Lu 177 Dotatate for Paediatric Patients 12 Years... 15 Μαΐου, 2024 Trametinib Is a New Treatment Option for Rare Form of Ovarian... 10 Μαρτίου, 2022 Φόρτωση περισσοτέρων HOT NEWS Curbing Production of Immune Checkpoint Protein Slows Liver Cancer in Mice Breast Cancer Survivor is Swimming the English Channel to Benefit Mental... UK health inequalities: 20,000 more cancer cases a year in the... What Survivors Should Know When Transitioning From Cancer Care to Primary...